檢索結果 - Massimo Iavarone

Refine Results
  1. 1
    Management of hepatocellular carcinoma in the time of COVID-19

    Management of hepatocellular carcinoma in the time of COVID-19 由 Massimo Iavarone, Angelo Sangiovanni, Gianpaolo Carrafiello, Giuliana Rossi, P. Lampertico

    出版 2020
    獲取全文
    Carta
    加到收藏夾
    Saved in:
  2. 2
    Low Resistance to Adefovir Combined With Lamivudine: A 3-Year Study of 145 Lamivudine-Resistant Hepatitis B Patients

    Low Resistance to Adefovir Combined With Lamivudine: A 3-Year Study of 145 Lamivudine-Resistant Hepatitis B Patients 由 Pietro Lampertico, Mauro Viganò, E. Manenti, Massimo Iavarone, Erwin Sablon, M. Colombo

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: The importance of tumor cell differentiation

    Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: The importance of tumor cell differentiation 由 Massimo Iavarone, Angelo Sangiovanni, Laura Forzenigo, Sara Massironi, Mirella Fraquelli, Alessio Aghemo, Guido Ronchi, Piero Biondetti, Massimo Roncalli, Massimo Colombo

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib

    Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib 由 Massimo Iavarone, Giuseppe Cabibbo, Marco Biolato, C. Della Corte, Marcello Maida, Marco Barbàra, Michele Basso, S. Vavassori, Antonio Craxı̀, Antonio Grieco, Carlo Cammà, Massimo Colombo

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment

    Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment 由 Giulio Antonelli, Elia Gigante, Massimo Iavarone, Paola Begini, Angelo Sangiovanni, Elsa Iannicelli, Piero Biondetti, Adriano Pellicelli, L. Miglioresi, Paolo Marchetti, Pietro Lampertico, Massimo Marignani

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Hepatic Fat—Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAs

    Hepatic Fat—Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAs 由 Elisabetta Degasperi, E. Galmozzi, Serena Pelusi, Roberta D’Ambrosio, R. Soffredini, Marta Borghi, Riccardo Perbellini, F. Facchetti, Massimo Iavarone, Angelo Sangiovanni, Luca Valenti, Pietro Lampertico

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab–bevacizumab resistance and worse survival in advanced hepatocarcinoma

    Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab–bevacizumab resistance and worse survival in advanced hepatocarcinoma 由 L. Gramantieri, Annapaola Montagner, Andrea Arleo, F. Suzzi, Cristian Bassi, Francesco Tovoli, Mariangela Bruccoleri, Eleonora Alimenti, Francesca Fornari, Massimo Iavarone, M. Negrini, Fabio Piscaglia, Catia Giovannini

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus‐related cirrhosis who attained sustained virological response

    Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus‐related cirrhosis who attained sustained virological response 由 Savino Bruno, V. Di Marco, Massimo Iavarone, Luigi Roffi, V. Boccaccio, Andrea Crosignani, Giuseppe Cabibbo, Sonia Rossi, Vincenza Calvaruso, Alessio Aghemo, Luca Giacomelli, Antonio Craxı̀, Massimo Colombo, Patrick Maisonneuve

    出版 2017
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    PNPLA3 I148M Polymorphism, Clinical Presentation, and Survival in Patients with Hepatocellular Carcinoma

    PNPLA3 I148M Polymorphism, Clinical Presentation, and Survival in Patients with Hepatocellular Carcinoma 由 Luca Valenti, Benedetta Maria Motta, Giorgio Soardo, Massimo Iavarone, Benedetta Donati, Angelo Sangiovanni, Alessia Carnelutti, Paola Dongiovanni, Raffaela Rametta, C. Bertelli, F. Facchetti, Massimo Colombo, Silvia Fargion, Anna Ludovica Fracanzani

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Experience With Early Sorafenib Treatment With mTOR Inhibitors in Hepatocellular Carcinoma Recurring After Liver Transplantation

    Experience With Early Sorafenib Treatment With mTOR Inhibitors in Hepatocellular Carcinoma Recurring After Liver Transplantation 由 Federica Invernizzi, Massimo Iavarone, Claudio Zavaglia, Stefano Mazza, U. Maggi, Lucia Cesarini, Barbara Antonelli, Aldo Airoldi, M.A. Manini, Angelo Sangiovanni, G. Rossi, Maria Francesca Donato, L Belli, Pietro Lampertico

    出版 2019
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma

    Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma 由 Luca Di Tommaso, Annarita Destro, Valentina Fabbris, Gaia Spagnuolo, Anna Laura Fracanzani, Silvia Fargion, Marco Maggioni, Carlo Patriarca, R Macchi, M. Quagliuolo, Mauro Borzio, Massimo Iavarone, Angelo Sangiovanni, Massimo Colombo, Massimo Roncalli

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection

    A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection 由 David Y. Zhang, Nicolas Goossens, Guo J, Ming‐Chao Tsai, Hsin-I Chou, Civan Altunkaynak, Angelo Sangiovanni, Massimo Iavarone, M. Colombo, Masahiro Kobayashi, Hiromitsu Kumada, Augusto Villanueva, Josep M. Llovet, Yujin Hoshida, Scott L. Friedman

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice

    Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clin... 由 Edoardo G. Giannini, Andrea Aglitti, Mauro Borzio, Martina Gambato, Maria Guarino, Massimo Iavarone, Quirino Lai, Giovanni Battista Levi Sandri, Fabio Melandro, Filomena Morisco, Francesca Romana Ponziani, Maria Rendina, Francesco Paolo Russo, Rodolfo Sacco, Mauro Viganò, Alessandro Vitale, Franco Trevisani

    出版 2019
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  14. 14
    Prognostic Gene Expression Signature for Patients With Hepatitis C–Related Early-Stage Cirrhosis

    Prognostic Gene Expression Signature for Patients With Hepatitis C–Related Early-Stage Cirrhosis 由 Yujin Hoshida, Augusto Villanueva, Angelo Sangiovanni, Manel Solé, Chin Hur, Karin L. Andersson, Raymond T. Chung, Joshua Gould, Kensuke Kojima, Supriya Gupta, Bradley Taylor, Andrew Crenshaw, Stacey Gabriel, Beatriz Mínguez, Massimo Iavarone, Scott L. Friedman, Massimo Colombo, Josep M. Llovet, Todd R. Golub

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    High rates of 30-day mortality in patients with cirrhosis and COVID-19

    High rates of 30-day mortality in patients with cirrhosis and COVID-19 由 Massimo Iavarone, Roberta D’Ambrosio, Alessandro Soria, M. Triolo, Nicola Pugliese, P. Del Poggio, Giovanni Perricone, Sara Massironi, Angiola Spinetti, Elisabetta Buscarini, Mauro Viganò, Canio Carriero, S. Fagiuoli, Alessio Aghemo, L Belli, Martina De Luca, Marianna Pedaci, Alessandro Rimondi, Maria Grazia Rumi, Pietro Invernizzi, Paolo Bonfanti, Pietro Lampertico

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE‐1 study

    VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE‐1 study 由 Mario Scartozzi, Luca Faloppi, Gianluca Svegliati‐Baroni, Cristian Loretelli, Fabio Piscaglia, Massimo Iavarone, Pierluigi Toniutto, Giammarco Fava, Samuele De Minicis, Alessandra Mandolesi, Maristella Bianconi, Riccardo Giampieri, Alessandro Granito, F. Facchetti, Davide Bitetto, Sara Marinelli, Laura Venerandi, S. Vavassori, S Gemini, Antonietta D’Errico, Massimo Colombo, Luigi Bolondi, Italo Bearzi, A. Benedetti, Stefano Cascinu

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration

    A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration 由 Lindsay Y. King, Claudia Canasto‐Chibuque, Kara B. Johnson, Shun H. Yip, Xintong Chen, Kensuke Kojima, Manjeet Deshmukh, Anu Venkatesh, Poh Seng Tan, Xiaochen Sun, Augusto Villanueva, Angelo Sangiovanni, Venugopalan D. Nair, Milind Mahajan, Masahiro Kobayashi, Hiromitsu Kumada, Massimo Iavarone, Massimo Colombo, Maria Isabel Fiel, Scott L. Friedman, Josep M. Llovet, Raymond T. Chung, Yujin Hoshida

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma

    Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma 由 Francesco Tovoli, Vincenzo Dadduzio, Stefania De Lorenzo, Lorenza Rimassa, Gianluca Masi, Massimo Iavarone, Fabio Marra, Ingrid Garajová, Maria Pia Brizzi, Bruno Daniele, Franco Trevisani, Carlo Messina, Francesco Clemente, Sara Pini, Giuseppe Cabibbo, Alessandro Granito, Mario Domenico Rizzato, Vittorina Zagonel, Giovanni Brandi, Tiziana Pressiani, Piera Federico, Caterina Vivaldi, Irene Maria Bambina Bergna, Claudia Campani, Fabio Piscaglia

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation

    Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation 由 Massimo Iavarone, Federica Invernizzi, Carolin Czauderna, Marco Sanduzzi‐Zamparelli, Sherrie Bhoori, Giuliana Amaddeo, M.A. Manini, Miguel Fraile López, Margarita Anders, Matthias Pinter, María José Blanco Rodríguez, Mario Romero Cristóbal, Gabriel Aballay Soteras, Federico Piñero, Gerda Elisabeth Villadsen, Arndt Weinmann, Gonzalo Crespo, Vincenzo Mazzaferro, Hélène Regnault, Massimo De Giorgio, M.L. González-Diéguez, Maria Francesca Donato, Marı́a Varela, Marcus‐Alexander Wörns, Jordi Bruix, Pietro Lampertico, María Reig

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial

    Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial 由 Vincenzo Mazzaferro, Davide Citterio, Sherrie Bhoori, Marco Bongini, Rosalba Miceli, Luciano De Carlis, M. Colledan, Mauro Salizzoni, Renato Romagnoli, Barbara Antonelli, Marco Vivarelli, Giuseppe Tisone, Massimo Rossi, Salvatore Gruttadauria, Stefano Di Sandro, Riccardo De Carlis, Maria Grazia Lucà, Massimo De Giorgio, S. Mirabella, L Belli, S. Fagiuoli, Silvia Martini, Massimo Iavarone, Gianluca Svegliati‐Baroni, M. Angélico, Stefano Ginanni Corradini, Riccardo Volpes, Luigi Mariani, Enrico Regalia, Maria Flores, Michele Droz Dit Busset, Carlo Sposito

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: